Compare TCOM & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCOM | WST |
|---|---|---|
| Founded | 1999 | 1923 |
| Country | Singapore | United States |
| Employees | 43574 | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7B | 25.6B |
| IPO Year | N/A | 2004 |
| Metric | TCOM | WST |
|---|---|---|
| Price | $46.43 | $339.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $78.75 | ★ $325.86 |
| AVG Volume (30 Days) | ★ 3.0M | 734.3K |
| Earning Date | 05-18-2026 | 04-23-2026 |
| Dividend Yield | ★ 0.57% | 0.30% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | N/A | ★ 4.07 |
| Revenue | N/A | ★ $2,886,900,000.00 |
| Revenue This Year | $15.73 | $6.76 |
| Revenue Next Year | $13.00 | $6.22 |
| P/E Ratio | ★ $9.06 | $82.91 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $38.04 | $223.83 |
| 52 Week High | $79.00 | $386.00 |
| Indicator | TCOM | WST |
|---|---|---|
| Relative Strength Index (RSI) | 59.97 | 44.12 |
| Support Level | $45.92 | $321.94 |
| Resistance Level | $54.81 | $367.66 |
| Average True Range (ATR) | 1.07 | 11.46 |
| MACD | 0.58 | -4.22 |
| Stochastic Oscillator | 77.48 | 20.07 |
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.